PrecivityAD2 Testing for Symptomatic Adults 40 and Older in 2026: Result Interpretation Questions for People With Mild Cognitive Impairment

Learn what your APS2 score means for MCI and which follow-up questions to bring to your memory clinic visit.

PrecivityAD2 testing in 2026 helps adults age 40 and older with symptoms, including mild cognitive impairment, assess the likelihood of Alzheimer's-related brain amyloid plaques. Mild cognitive impairment means noticeable memory or thinking changes beyond normal aging that do not yet prevent daily life.

The test returns an Amyloid Probability Score 2 from 0 to 100 to guide next steps with a clinician. C2N Diagnostics announced FDA clearance on August 20, 2026 for adults with signs or symptoms of cognitive impairment being evaluated for Alzheimer's disease, according to the company announcement. It is intended to supplement, not replace, a standard clinical workup.

Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.

Table of Contents

What does your APS2 score mean?

PrecivityAD2 uses high-resolution mass spectrometry to measure plasma amyloid-beta 42/40 ratio and percent phosphorylated tau217. Those results combine into the Amyloid Probability Score 2. The score estimates the likelihood of brain amyloid plaques.

Mayo Clinic Laboratories reports APS2 as Negative 0-47 and Positive 48-100, indicating low versus high likelihood of plaques, according to the Mayo Clinic Laboratories catalog. A negative score does not rule out all causes of memory change. A positive score does not by itself diagnose Alzheimer's disease.

How accurate are clear results for symptomatic adults?

In C2N's 1,142-person symptomatic validation cohort, results showed 97.6% positive predictive value and 93.1% negative predictive value versus amyloid PET or spinal fluid testing, according to the NeurologyLive report. Positive predictive value means how often a positive result matched plaque on PET or spinal fluid. Negative predictive value means how often a negative result matched absence of plaque.

For a person with mild cognitive impairment, a clear result therefore carries strong weight. It still needs clinical context such as history, exam, cognition testing, and other labs. Other conditions can also cause mild cognitive impairment without amyloid plaques.

What does an intermediate likely positive result mean?

An intermediate likely positive result occurred in 17.3% of validation patients. In that subgroup, positive predictive value was lower at 77.3%.

That means roughly one in four intermediate results did not match plaque on PET or spinal fluid. People with mild cognitive impairment in this range need careful counseling. Ask whether repeat testing, PET, spinal fluid analysis, or watchful follow-up fits your case.

What this blood test cannot do alone?

PrecivityAD2 is not cleared for screening people without symptoms. It is also not cleared as a stand-alone diagnosis.

Practical Neurology reports the test must supplement standard clinical workup by experienced clinicians, as described in the Practical Neurology report. Use depends on age 40 or older plus signs or symptoms under evaluation. C2N said its CLIA-validated laboratory version remained available through its clinical laboratory while the FDA-cleared version was expected later in 2026.

What should you bring to the follow-up visit?

Bring your exact APS2 number, test date, current medicines, sleep and mood changes, and examples of daily tasks affected. Ask how the result fits other findings and whether referral to a memory specialist is needed. Write down the plan for follow-up testing, symptom tracking, and caregiver support before you leave the visit.

  • Ask what your score range suggests for amyloid likelihood
  • Ask whether PET, spinal fluid, MRI, or blood retesting is warranted
  • Ask how treatment, trial, safety, driving, and care-planning options change
  • Ask when to repeat cognitive testing

You Might Also Like

HelpDementia.com

Dementia, Alzheimer's, Caregiving & Healthy Aging Guidance

© 2026 HelpDementia.com. All rights reserved.

Educational information only. It is not medical advice and does not replace care from a qualified clinician.